Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fuji
Argus Health
AstraZeneca
Daiichi Sankyo
Boehringer Ingelheim

Generated: June 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TOLCAPONE

« Back to Dashboard

Clinical Trials for Tolcapone

Trial ID Title Status Sponsor Phase Summary
NCT00033059 Assessment of Potential Interactions Between Cocaine and Tolcapone - 1 Unknown status National Institute on Drug Abuse (NIDA) Phase 1 The purpose of this study is to assess the potential interactions between intravenous (IV) cocaine and tolcapone.
NCT00044083 Clinical Trial of Tolcapone for Cognition in Schizophrenia Completed National Institute of Mental Health (NIMH) Phase 2 This study will evaluate whether Tolcapone improves cognition in healthy volunteers as well as patients with schizophrenia. Talcapone is a drug that has been FDA approved for Attention Deficit Disorder and allegedly increase the amount of the neurotransmitter dopamine in the frontal cortex of the brain.
NCT00548327 The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype Terminated National Institute of Mental Health (NIMH) Phase 2 This study will evaluate whether Atomoxetine improves cognition in healthy volunteers as well as patients with schizophrenia. Atomoxetine is a drug that has been Food and Drug Administration (FDA) approved for Attention Deficit Disorder and allegedly increase the amount of the neurotransmitter dopamine in the frontal cortex of the brain.
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Tolcapone

Condition Name

Condition Name for Tolcapone
Intervention Trials
Alcohol Use Disorder 2
Schizophrenia 2
Pathological Gambling 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Tolcapone
Intervention Trials
Disease 3
Tobacco Use Disorder 3
Brain Injuries 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Tolcapone

Trials by Country

Trials by Country for Tolcapone
Location Trials
United States 26
Sweden 1
United Kingdom 1
Germany 1
Switzerland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Tolcapone
Location Trials
California 6
South Carolina 3
Pennsylvania 3
Maryland 3
Connecticut 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Tolcapone

Clinical Trial Phase

Clinical Trial Phase for Tolcapone
Clinical Trial Phase Trials
Phase 4 2
Phase 2/Phase 3 1
Phase 2 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Tolcapone
Clinical Trial Phase Trials
Completed 7
Not yet recruiting 4
Active, not recruiting 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Tolcapone

Sponsor Name

Sponsor Name for Tolcapone
Sponsor Trials
University of California, San Francisco 5
University of California, Berkeley 3
Corino Therapeutics, Inc. 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Tolcapone
Sponsor Trials
Other 25
NIH 6
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Chubb
Farmers Insurance
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.